Needle-nerve stimulation has a false negative motor response rate, which may increase needle passes. This prospective, randomised study tested the hypothesis that femoral nerve catheters placed with ultrasound-only guidance could provide comparable postoperative analgesia to those placed using a conventional nerve stimulation endpoint. Patients presenting for major knee surgery to the lead investigator were recruited. Needles introduced for femoral nerve catheter placement were initially guided with 'oblique' out-of-plane ultrasound imaging but were then prospectively randomised to either an ultrasound (n=21) or nerve stimulation (n=24) endpoint. An elastomeric infusion of ropivacaine 0.2% 2 ml/hour with as required hourly 5 ml boluses was continued for >48 hours in hospital and/or in the home. Needle time under the skin and numerical rating pain score during insertion were recorded. Patients were questioned for worst numerical rating pain score, the need for supplementary ropivacaine boluses and tramadol on postoperative days one and two. There was no difference in the worst numerical rating pain score at rest and on movement and the requirement for supplementary ropivacaine boluses or tramadol during the first 48 postoperative hours. The median (quartiles) needle time under the skin was 58 seconds (51 to 76) in the ultrasound group and 120 seconds (95 to 178) in the nerve stimulation group (P=0.001). The median (quartiles) insertion numerical rating pain score was 2 (0 to 2) in the ultrasound group and 4 (2 to 6) in the nerve stimulation group (P=0.014). Femoral nerve catheters placed for major knee surgery using an ultrasound endpoint provided postoperative analgesia comparable to that obtained when using a nerve stimulation endpoint and were associated with a reduction in both needle manipulations and procedure-related pain.
Continuous femoral block provides potent postoperative analgesia following both anterior cruciate ligament reconstruction (ACLR) 1,2 and total knee joint replacement (TKJR) 3 and is increasingly being used on an ambulatory basis 1, 4, 5 . Accurate femoral nerve catheter placement is advantageous in that low background infusions can be used effectively 6 , which enables more prolonged analgesia through the avoidance of early ambulatory pump depletion. Accurate catheter placement however, can be technically challenging.
In contrast to a surface landmark based neurostimulation technique for femoral nerve block, ultrasound imaging of the femoral area can provide important information about appropriate depth to the femoral neurovascular structures [7] [8] [9] . It can also be useful in patients with challenging surface anatomy. Studies have shown that the neurostimulation technique for perineural catheter placement carries a high false negative motor response rate 10 , which may increase needling. Unnecessary needling may increase catheter placement time and needle nerve contact. Reducing blind femoral nerve contact may also reduce the risk of femoral nerve needle trauma 11 .
To date, prospective randomised comparisons of ultrasound and neurostimulation as needle endpoints for femoral nerve catheter placement have not been reported. The primary hypothesis tested was that femoral nerve catheters placed using an ultrasound needle endpoint would be associated with postoperative analgesia of comparable quality to those placed using a neurostimulation endpoint. This was in the context of a non-stimulating catheter advanced via a Tuohy needle initially guided using ultrasound. Secondary endpoints included needle UltrasoUnd-gUided continUoUs femoral block Anaesthesia and Intensive Care, Vol. 37, No. 5, September 2009 manipulations and pain during femoral nerve catheter insertion.
MATeRIALS AND MeTHODS
After obtaining institutional review board approval (New Zealand Northern y Regional ethics Committee), all patients scheduled for elective hamstring graft ACLR and TKJR by a single surgeon (TD-C) in the principal investigator's practice from March through December 2008 were included. exclusions included patient refusal of femoral nerve block, known neuropathy involving the leg undergoing surgery, known allergy to amide local anaesthetic drugs and patients less than 85 kg scheduled for bilateral TKJR. Initial invitation to participate in the study occurred in the surgeon's rooms. Approximately one week prior to surgery, patients were contacted by a research assistant to provide further information. Written informed consent was obtained from all patients. Randomisation to the ultrasound and neurostimulation group was with a pre-prepared computer generated random number.
Nerve blocks
A single operator (MF) experienced in ultrasoundguided regional anaesthesia placed a femoral and sciatic block 12 in all patients. Premedication was with oral paracetamol 1.0 g, diclofenac SR 75 mg and omeprazole 20 mg. When diclofenac was not administered, intravenous parecoxib 40 mg was administered at the time of surgery. Five minutes prior to block placement, intravenous midazolam 2 mg, alfentanil 0.5 mg and cephazolin 1.0 g were administered to all subjects.
Sciatic block
Sciatic blocks were performed at the level of the distal thigh with the patient in the prone position [13] [14] [15] . The probe was placed just cephalad of the popliteal crease with proximal scanning until the best image of the sciatic nerve was obtained proximal to the tibial/common peroneal bifurcation. In-plane needle imaging was used from the right side of the patient's bed (right leg, medial to lateral and left leg, lateral to medial). Concomitant neurostimulation was used depending on the quality of the ultrasound images obtained 13 but ultimately in all patients the needle was repositioned as necessary to surround the sciatic nerve with 20 ml ropivacaine (ACLR=0.375%, TKJR=0.5%).
Femoral catheter
A 38 mm 13-6 MHz linear ultrasound probe (SonoSite HFL, Bothell, WA, USA) was placed in the coronal plane at approximately the level of the inguinal crease with the intention of visualising the femoral artery, vein and nerve ( Figure 1 ) (Sonosite M-Turbo/MicroMaxx/180, Bothell, WA, USA) 16 . Under ultrasound guidance, the skin and subcutaneous tissue in the femoral-inguinal area was infiltrated down to the iliacus muscle with 5 to 10 ml 1% lignocaine with adrenaline (1/200,000). The needle was kept at least 2 to 3 cm from the femoral nerve at all times. A 5.1 cm insulated Tuohy needle (Contiplex Tuohy, B. Braun, Bethlehem, PA, USA) connected to a nerve stimulator (Pajunk Vario, Tucker, gA, USA) set at 1.0 mA (pulse width 0.1 ms) was inserted at a point approximately 3 cm caudal to the ultrasound probe and approximately 2 to 3 cm lateral to the femoral nerve. The needle was then advanced superficially in a cephalad and medial direction into the subcutaneous tissue until tissue displacement was observed just lateral to the femoral nerve. If the figUres 1a and 1b: Ultrasound-guided femoral nerve catheter placement. (Reproduced with permission from elsevier). Figure 1A (ultrasound image of right femoral region) and 1B (needle-probe alignment during ultrasound guided femoral catheterisation). FL=fascia lata, FI=fascia iliaca, FN=femoral nerve with its indistinct lateral margin, FA=femoral artery, I=iliacus muscle, NT=path of needle-tip to achieve out-of-plane placement near the central posterior aspect of femoral nerve, A=classic out-of-plane needle approach to the femoral nerve, A1=plunger path required to achieve the needle-tip path (NT) depicted in Figure 1A , B='oblique' out-of-plane needle approach to the femoral nerve.
Anaesthesia and Intensive Care, Vol. 37, No. 5, September 2009 lateral margin of the femoral nerve was indistinct, a position approximately 2 to 3 cm lateral to the femoral artery was chosen. The needle was then placed into the iliacus muscle using the 'walk-down' technique 17 . At this point the needle was angled under the femoral nerve using a semicircular motion of needle hub/tip (Figure 1 ) 16 . The bevel of the needle was orientated posteriorly throughout in order to keep the curved/smooth aspect of the Tuohy tip facing the nerve.
Neurostimulation group
At the point where tissue displacement was noted posterior to the femoral nerve, the tip of the needle was directed superficially/anteriorly until a patellar twitch was elicited. If close needle-nerve proximity was observed on ultrasound in the absence of an appropriate patella response, the needle was directed slightly in-out, medial-lateral or rotated until a response was evoked. If after four minutes of needle manipulation a response was not obtained, the needle was removed and the needle was directed superficially in a cephalad direction straight down towards the superficial/anterior aspect of the femoral nerve until an appropriate patellar response was evoked. The ultrasound probe was then removed, the current progressively reduced and the needle manipulated to a point where muscle contractions were present at a stimulus intensity of 0.2 to 0.5 mA. If a patellar response could not be evoked after five minutes of needle manipulation (one minute after attempting needle-tip placement anterior to the femoral nerve), an ultrasound needle endpoint posterior to the femoral nerve was used. Five ml of dextrose 5% was injected via the needle prior to catheter advancement 18 .
Ultrasound group
Nerve stimulation was not used. The initial needle path was as for the neurostimuation group, with the target needle endpoint immediately posterior to the femoral nerve. Final needle-tip position was determined by the injection of 5 ml dextrose 5% and observation of satisfactory injectate spread, which was defined as spread within the iliacus muscle immediately posterior to the femoral nerve. The contingency plan, if a satisfactory ultrasound image could not be obtained within five minutes from the time the needle had entered the skin, was to use the nerve stimulator, to seek a 0.5 mA needle endpoint.
In both groups, a non-stimulating catheter was then advanced blindly 3 to 4 cm past the needletip. Following standard intravascular injection precautions, 30 ml ropivacaine 0.5% was administered through the catheter. In those patients undergoing bilateral TKJR, ropivacaine 0.375% was used for all blocks.
Intraoperative management
All patients were given a standardised general anaesthetic using a laryngeal mask airway, volatile anaesthesia and spontaneous respiration (eTMAC=0.8 to 1.2). Sensory and motor testing of either the sciatic or femoral block prior to surgery was not performed. No long-acting opioid was administered. However, alfentanil 0.25 mg was given pro re nata (prn) for a respiratory rate >25 /min.
Postoperative management
Patients reporting a numerical rating pain score (NRPS) >2 (on 0 to 10 scale) on emergence in the post anaesthesia care unit (PACU) were administered intravenous morphine 2 mg every three to five minutes to achieve a NRPS less than or equal to two. Catheter fixation and ambulatory management was similar to that previously described for ambulatory continuous interscalene block 19 . Specifically, the femoral nerve catheter was connected to an elastomeric infusion device (PainBuster, Surgical Synergies, Auckland, NZ) containing ropivacaine (ACLR=0.2%, TKJR=0.3%). This device delivers a continuous infusion of 2 ml/hour and has a patient controlled bolus capability of an additional 5 ml every hour. Postoperative paracetamol (1 g every 6 hours) and diclofenac SR (75 mg every 12 hours) were continued for as long as ropivacaine boluses were required. Tramadol 100 mg SR every 12 hours was added for those patients who despite regular paracetamol, diclofenac and ropivacaine boluses, had a NRPS >3. An opioid was administered if pain persisted despite tramadol (oral morphine for NRPS >3, intravenous morphine for NRPS >5). Management was then according to the surgical procedure as follows:
ACLR: Discharge to home with the elastomeric pump occurred on the day of surgery. Patients were instructed to clamp the infusion off on postoperative day two. If pain remained less than or equal to two after four hours, patients removed the catheter without medical assistance. If pain increased (NRPS >2) while the infusion was off, the infusion was restarted and continued for a further 24 hours.
TKJR: Home discharge occurred from postoperative day two depending on social circumstances and demonstration of standard self-mobilisation and activities of daily living criteria. Prior to home discharge, the catheter infusion was given a trial period off. If pain did not increase with the infusion off, the catheter was removed. If pain increased such that the NRPS was >2 despite paracetamol, diclofenac and tramadol, the infusion was restarted and discharge to home occurred with the elastomeric pump. In these patients, the catheter was removed without medical assistance once the reservoir was empty.
Data collection
Data collection was divided into four parts (person recording data in parentheses):
At the time of catheter insertion (principal 1.
investigator). Needle time under the skin (as an indirect measure of the number of needle manipulations) was recorded. Needle time under the skin was defined as the time from the needletip penetrating the skin until exiting the skin over the catheter. The minimal (mA) twitch amplitude was also recorded. Subjects were asked by the principal investigator, following catheter fixation but prior to induction of general anaesthesia, "How would you rate your discomfort with what we just did on a scale of 0 to 10 if 0 is no discomfort and 10 is the worst discomfort imaginable?" If a range of scores were reported (e.g. two to three), the highest score was recorded. During surgery (principal investigator).
2.
The number of boluses of alfentanil 0.25 mg administered for a respiratory rate greater than 25 /min was recorded.
In the PACU (primary PACU nurse and principal 3.
investigator). The patients' primary PACU nurse recorded the patients' NRPS and morphine consumption. Patients reporting postoperative pain were assessed by the principal investigator for sensation to cold in the cutaneous distribution of the femoral, lateral femoral cutaneous, obturator and sciatic nerves in relation to the contralateral leg. On postoperative day one to day two (research 4. assistant). All patients were phoned either at home or in hospital on the afternoon of postoperative days one and two and questioned regarding knee pain, ropivacaine bolus administration and tramadol consumption. On postoperative day two, satisfaction with the technique was also assessed.
For bilateral TKJR, tramadol and morphine were administered according to the study protocol but assigned to each leg according to the NRPS in each knee (e.g. if a NRPS >3 was reported in both knees, and this necessitated tramadol according to the study protocol, then tramadol was assigned to both knees).
At the end of the study period, a research assistant reviewed the hospital records of all study patients to verify, where possible, the accuracy of data obtained verbally from subjects. Data verified from the medication record included PACU morphine administration, ward tramadol/ropivacaine boluses and if required, morphine consumption. The specific day of discharge was verified, as was confirmation of ambulatory management of the catheter.
Blinding of treatments
The aim of data collection was to blind both subjects and observers to the treatment groups throughout the study. During the informed consent process, preoperative information was limited to a discussion of the benefits and risks of a femoral nerve catheter and a general discussion of the two neurolocalisation methods. 'Twitches' were not mentioned until immediately prior to stimulation of the femoral nerve, i.e. after the administration of midazolam. Data collection during femoral nerve catheter insertion and surgery was not blinded. Details of the catheter insertion were recorded on the study data sheet and not on the anaesthesia record. The PACU, ward staff and research assistant were thus blinded to treatment group at the day one and two consultation.
The surgeon saw all patients on postoperative day seven and catheter entry sites were inspected at this consultation.
Statistical analysis
Normal distribution of the data was first evaluated using the Kolmogorov-Smirnov test. Differences in surgery type and gender between the two groups were tested using the chi-square test. Age and weight differences were examined using the two-sample Student's t-test. Two-sided tests were used for these group comparisons. Needle time under the skin and insertion pain score were compared between the two groups using the Mann Whitney U test. The proportion of patients requiring tramadol was compared using the chi-square test. The intraoperative alfentanil, PACU morphine, postoperative ropivacaine and tramadol consumption for each day were compared using the Mann Whitney U test. A P value of less than 0.05 was considered significant in all cases, with two-sided tests used for all experimental outcomes. Statistical analysis was with Prism 5.0a for Mac OS X (graphpad Software Inc, La Jolla, CA, USA).
The sample size was based on postoperative pain. Previous studies involving a similar mix of TKJR and ACLR surgeries were assumed to have a standard deviation of 2.5 points on the 11-point NRPS 20 . Detection of more than a two-point shift in mean pain required 20 subjects in each group (two-sided one sample t-test, power 80% at P=0.05). Because of the known limitations of necessitating a neurostimulation needle endpoint, an increase in mean postoperative pain of less than 2 points (0 to 10) in the ultrasound group was considered clinically acceptable for the purpose of this pilot study.
ReSULTS
Forty-two patients presenting for major knee surgery to the principal investigator were recruited during the study period. Three patients underwent bilateral TKJR (ultrasound=3, neuro-stimulation=3), therefore 45 femoral catheters were placed. Two elderly patients were excluded due to confusion during the postoperative period. There were no differences in patient and surgical characteristics between the two groups ( Table 1) . Catheter placement details are presented in Table 2 . All patients were sufficiently alert at the time of questioning for procedure-related pain (approximately 10 minutes after sedation was administered). The ultrasound endpoint was associated with a 60 second reduction in the median needle time under the skin (P=0.001) and lower insertion pain scores (P=0.014). In five patients in the neurostimulation group, a patellar response could not be elicited within four minutes, therefore the needle was directed towards the superficial/ anterior of the femoral nerve. In one patient, a satisfactory patellar response could not be obtained after five minutes, therefore an ultrasound endpoint was used. All patients in group ultrasound had their catheter placed without nerve stimulation. There was no difference between ultrasound and neurostimulation in the requirement for morphine in the PACU (Table 3) , nor was there any difference in the requirement for ropivacaine boluses, tramadol or morphine consumption or pain scores on postoperative days one or two (Table 3 and Figure 2 ). Post-hoc power analysis was also performed. NRPS (0 to 10) at rest had a standard deviation of 2.4 points in both groups, thus validating the original power analysis. Similar analysis revealed that the study was powered to detect a mean shift of 1.1 and 2.3 ropivacaine boluses on days one and two respectively, and a difference in a mean tramadol consumption of 0.5 tablets on each postoperative day (one sample t-test, power=80%, alpha=0.05, twotailed).
In those patients who reported postoperative pain in the PACU, incomplete sensory blockade to cold was present in two, eight, seven and 14 femoral, lateral femoral cutaneous, obturator and sciatic nerve territories respectively. No differences were noted between treatment groups. Median (quartiles) numerical rating satisfaction score (0 to 10) was 9 (8 to 10) in each group.
Median (quartiles)[range] postoperative day of discharge for patients undergoing TKJR was 3 (3 to 4)[2 to 5]. Four patients undergoing TKJR managed their femoral catheter at home from postoperative days two to five.
No patient developed symptoms or signs of central nervous system or cardiac toxicity. Two patients undergoing TKJR sustained a minor inconsequential fall, both on postoperative day one. However, several possible aetiological factors were present in both patients, including probable residual quadriceps weakness from the primary surgical block. No patient had local signs of catheter infection at the day seven surgical consultation. 
DISCUSSION
This study compared femoral nerve catheters placed for postoperative analgesia following major knee surgery using two different needle endpoints. Non-stimulating femoral nerve catheters placed using an ultrasound endpoint with an oblique needle-probe out-of-plane alignment technique were associated with comparable postoperative analgesia to those placed using a neurostimulation needle endpoint. The ultrasound endpoint was associated with less needling and less procedure-related pain. These results are similar to those observed in a similar study performed in the interscalene region 21 .
To the best of the authors' knowledge, this is the first prospective randomised trial comparing ultrasound and neurostimulation endpoints for femoral catheter placement. Previous studies comparing these two neurolocalisation methods have involved single injection techniques and have centred on the ability of ultrasound guidance to enable a repositioning of the block needle during local anaesthetic deposition. Thus, both lower anaesthetic doses and more rapid onset times with ultrasound have been shown 7 . Perineural catheter placement can be regarded as being similar to a single-point single-injection technique. Block effectiveness with such a technique is dependent on the accuracy of needle placement, such that catheters are in a position that optimises local anaesthetic spread in relation to the target neural elements. In this regard, the interscalene and femoral areas differ in that the interscalene area consists of a plexus whereas the femoral area contains a single large nerve. For shoulder surgery, it is well accepted that the most appropriate location for local anaesthetic placement is at a specific point of the brachial plexus; the C5-6 roots or superior trunk. The most appropriate position for local anaesthetic placement on the surface of the femoral nerve is less well understood. Catheter function in this area is possibly more dependent on simply the proximity of a catheter in relation to the nerve rather than positioning near a specific point on the surface of the nerve.
Ultrasound was used for initial needle guidance in both groups. In the neurostimulation group, if a motor response was not elicited despite close needle-nerve proximity on ultrasound, the needle was manipulated until a response was evoked. Ultrasound may have therefore further minimised unnecessary needle withdrawals/reinsertions and therefore needle time under the skin when compared with a technique utilising neurostimulation only.
Non-stimulating catheters were used in this study. Catheter threading was performed blind a distance of 3 to 4 cm beyond needle-tip once the appropriate needle endpoint had been obtained. Although catheter position can be verified with both ultrasound and neurostimulation [22] [23] [24] , it is not our practice to do so as it is unlikely that stimulation or visualisation of a catheter inserted <3 to 4 cm past the needle-tip would result in any further catheter intervention 25, 26 .
This study was powered to only detect a shift of two NRPS points, in part because of the inherent variability in postoperative pain as a result of the inclusion of patients having two distinctly different surgical procedures. The inclusion of patients having both ACLR and TKJR surgeries was necessary in order to recruit sufficient subjects during the course of the study. The apparent lower median pain scores in group neurostimulation on 'eye-balling' the data on both days one and two (Figure 2 ) raises the possibility that a true difference existed, such that the catheters placed with the ultrasound endpoint were not placed as accurately as those placed with the neurostimulation endpoint. An oblique out-ofplane needle-probe alignment technique was used in the ultrasound group. More accurate catheter placement might be obtained with an in-plane technique approaching the femoral nerve from lateral to medial or alternatively along the long axis of the nerve; however, reports of this method for perineural catheter placement are limited to case reports 27 . Finally, different ultrasound machines were used, one of which (SonoSite 180) has become largely superseded. Better results might be expected in the ultrasound group if the study was conducted uniformly with more current machines, as these generally have better image quality.
A novel aspect of this study was the administration of continuous femoral block on an ambulatory basis. In comparison to continuous brachial plexus blockade, continuous femoral block has the added challenge of potential weakness in an extremity that is necessary for mobilisation, which may theoretically increase the risk of falls 28 . Previous reports of continuous femoral block have occurred largely in the in-patient setting, however the technique is being used increasingly in the ambulatory environment, particularly in North America 1, 4, 5 . Advantages of ambulatory management include reduced cost through reduced length of hospital stay 4,5 and at least theoretically, a reduced risk of nosocomial infection and immobility-related venous thrombosis. Our experience, albeit limited by small numbers, is similar to previous reports in that the technique was well tolerated and associated with a high degree of patient satisfaction. The study therefore adds further support to the ongoing use of this treatment in the ambulatory setting. This study also demonstrates that these analgesia techniques can be used successfully in a private practice ambulatory setting.
There are several important limitations to this study. We chose needle time under the skin as the most reliable measure of needle manipulations. Having an observer count the needle manipulations would have added observer bias to this assessment. It should be recognised, however, that catheter threading comprised part of the needle time under the skin. It is possible, though nonetheless unlikely, that one of the two treatment groups influenced the catheter threading time. Finally, a single operator experienced in both neurolocalisation techniques placed all catheters. A single operator is advantageous with respect to reducing interoperator variability. However, both placement methods have an inevitable learning curve and this could limit the study's external validity, depending on an individual operator or department's experience base. The results may not therefore be generalisable to settings with less experienced operators. In these settings, a neurostimulation endpoint may represent a more objective indicator of correct needle-tip position.
In summary, this pilot study shows that femoral nerve catheters placed for major knee surgery using an oblique out-of-plane ultrasound technique and ultimately an ultrasound endpoint provide postoperative analgesia that is comparable to that obtained when using a neurostimulation endpoint. Compared with a neurostimulation endpoint, the ultrasound endpoint enabled a reduction in needling and was associated with reduced procedure-related pain. These results are similar to that observed in the interscalene area.
